α1 and α2-adrenergic agonists on cirrhotic patients with refractory ascites

Liver Int. 2016 Feb;36(2):177-80. doi: 10.1111/liv.12941.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Adrenergic alpha-2 Receptor Agonists*
  • Ascites*
  • Humans
  • Liver Cirrhosis

Substances

  • Adrenergic alpha-2 Receptor Agonists